Option chain shows key data for Edesa Biotech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Edesa Biotech.

Edesa Biotech (NASDAQ:EDSA) Stock, Option Chain

Edesa Biotech

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Wall Street_Dow

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

BROS

DGLY

EDSA

Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings

Nasdaq index

Intraday Update

CSCO

Nasdaq Surges 150 Points; Cisco Earnings Top Views

Us,Financial,Inflation,Crisis,With,Stock,Market,Graph,,,Economy

AMOD

US Stocks Edge Higher; Producer Prices Increase In January

Edesa Biotech Inc

Biotech

Press Releases

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

Edesa Biotech Announces Upcoming Conference Schedule

Financing

Edesa Biotech's Founder Makes Strategic Investment in the Company

Edesa Biotech Reports Fiscal Year 2024 Results

Management

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Comments

Edesa Biotech

Edesa Biotech (EDSA) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell